Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens - EP3246044

The patent EP3246044 was granted to Wyeth on Apr 10, 2024. The application was originally filed on Aug 22, 2011 under application number EP17172800A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3246044

WYETH
Application Number
EP17172800A
Filing Date
Aug 22, 2011
Status
Patent Maintained As Amended
Mar 8, 2024
Grant Date
Apr 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFI PASTEURSep 29, 2021CABINET NONY -
SANOFI PASTEURSep 29, 2021IPSILON -

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006257413
DESCRIPTIONUS2009202593
DESCRIPTIONWO0018434
OPPOSITIONCA2808975
OPPOSITIONEP2608805
OPPOSITIONWO2004032958
OPPOSITIONWO2007127665
OPPOSITIONWO2010009323
OPPOSITIONWO2010109323
OPPOSITIONWO2011161653
SEARCHUS2006257413
SEARCHUS2009035328
SEARCHUS6245892
SEARCHWO2009050586
SEARCHWO2009104097
SEARCHWO2009158142

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- EGAN ET AL., VACCINE, (2009), vol. 27, no. 24, pages 3175 - 3180
DESCRIPTION- MCNEIL ET AL., VACCINE, (2009), vol. 27, pages 3417 - 3421
DESCRIPTION- SEDEGAH ET AL., PNAS, (1994), vol. 91, pages 9866 - 9870
DESCRIPTION- WOLFF ET AL., BIOTECHNIQUES, (1991), vol. 11, no. 4, pages 474 - 85
OPPOSITION- Anonymous, "Guidelines on stability evaluation of vaccines WHO/BS/ 06/2049", World Health Organization, (20060000), pages 1 - 28, XP055850575
OPPOSITION- Hoffmann C., Blume A., Miller I., Garidel P., "Insights Into protein-polysorbate interactions analysed by meansof isothermal titration and differential scanning calorimetry", European Biophysics Journal, (20090203), vol. 38, no. 5, pages 557 - 568, XP019705321
OPPOSITION- Hoffmann et al Eur Biophys J 2009;38(5):557-568
OPPOSITION- Jiang H Q; Hoiseth S K; Harris S L; McNeil L K; Zhu D; Tan C; Scott A A; Alexander K; Mason K; Miller L; DaSilva I; Mack M; Zhao X J; Pride M W; Andrew L; Murphy E; Hagen M; French R; Arora A; Jones T R; Jansen K U; Zlotnick G W; Anderson A S, "Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease", Vaccine, (20100707), vol. 28, no. 37, pages 6086 - 6093, XP027204839
OPPOSITION- LINKE D., "Detergent: an overview", Methods in Enzymology, (20090000), vol. 463, pages 603 - 617, XP009179347
OPPOSITION- Matheis W., Zott A., Schwanig M., "The role of the absorption process for production and control combined absorbed vaccines", Vaccine, (20010000), vol. 20, no. 1-2, pages 67 - 73, XP055850584
OPPOSITION- Vessely C., Estey T., Randolph T. W., Henderson I., Nayar R., Carpenter J. F., "Effects of solution conditions and surface chemistry on the absorption of three recombiant Botulinum Neurotoxin antigens to aluminum salt adjuvants.", Journal of Pharmaceutical Sciences, (20070900), vol. 96, no. 9, pages 2375 - 2389, XP055850591
OPPOSITION- Zheng Y., Lai X., Ipsen H., Nedergaards Larsen J., Lowenstein H., Sondergaards I., Jacobsen S., "The structural stability of protein antigens absorbed by aluminium hydroxide in comparison to the antigens in solutions", Journal of Spectroscopy, (20070000), vol. 21, pages 257 - 268, XP055850599
OPPOSITION- Kerwin B. A., "Polysorbates 20 and 80 used in the formulation of protein biotherapeutics : Structure and degradation pathways", JPharm Sci., (20080800), vol. 97, no. 8, pages 2924 - 2935, XP055015864
OPPOSITION- Manning M. C., Chou D. K., Murphy B. M., Payne R. W., Katayama D. S., "Stability of protein pharmaceuticals : an update", Pharmaceutical Research, (20100209), vol. 27, no. 4, pages 544 - 575, XP019793935
OPPOSITION- Teerlink T., Beuvery E. C., Evenberg D., Van Wezel T. L., "Synergistic effect of detergents and aluminium phosphate on the humoral immune response to bacterial and viral membrane proteins", Vaccine, (19871200), vol. 5, no. 4, pages 307 - 314, XP023899852
OPPOSITION- Wang W., Wang Y. J., Wang D. Q., "Dual effects of Tween 80 on protein stability", International Journal of Pharmaceutics, (20080000), vol. 347, no. 1-2, pages 31 - 38, XP055355845
OPPOSITION- Pajon R; Beernink P T; Harrison L H; Granoff D M, "Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates", Vaccine, (20100225), vol. 28, no. 9, pages 2122 - 2129, XP026921802
OPPOSITION- HOGENESCH, "Mechanisms of stimulation of the immune response by aluminum adjuvants", Vaccine, (20020531), vol. 20, pages S34 - S39, XP004361371
SEARCH- HOUGHTEN R A, "GENERAL METHOD FOR THE RAPID SOLID-PHASE SYNTHESIS OF LARGE NUMBERS OF PEPTIDES: SPECIFICITY OF ANTIGEN-ANTIBODY INTERACTION AT THE LEVEL OF INDIVIDUAL AMINO ACIDS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC; US, (19950801), vol. 82, doi:10.1073/PNAS.82.15.5131, ISSN 0027-8424, pages 5131 - 5135, XP000611717 [A] 1-22 * page 5132, column l, line 26 - column r, line 12 *
SEARCH- MASIGNANI V ET AL, "Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, (20030317), vol. 197, no. 6, doi:10.1084/JEM.20021911, ISSN 0022-1007, pages 789 - 799, XP002286107 [A] 1-22 * page 791, column r, lines 51-60 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents